CronosThe cannabis stock selloff of 2019 has eroded value throughout the market. While many mainstream investors will see the environment as extremely risky, alternative investors can find bargain stocks that are primed for growth in the coming years. Cronos Group Inc. (NASDAQ: CRON) is a popular cannabis stock that holds a lot of value for investors who are willing to wait out the current dip.

Cronos is a cannabis producer that sells in legal markets like Canada and Germany. It has generated five consecutive years of top-line growth, indicating that its business continues to expand as cannabis becomes legalized for medical and recreational use in key global markets. Although the United States is yet to legalize cannabis at a federal level, there is growing support for legislation in Congress. Many alternative investors are betting on a completely legalized U.S. market within the next ten years.

Even if the U.S. doesn’t legalize, Cronos can still expand, thanks to its well-established growth, processing, and distribution business. This stock is a regular pick for bargain alternative stocks, and in December it looks as promising as in recent months. Trading volume increased this week and the stock saw positive movement on Monday. With a target price just below $10, investors could see an upside within the coming months. Long-term, this is one of the most promising cannabis stocks on the market.

Key Data:

  • 1 Year Price Growth: -36.09%
  • YTD Price Growth: -37.44%
  • 3 Month Price Growth: -41.02%

All information is based on current and historical market data, as well as publicly available financial data. As with any financial decision, your own research is important. Stock market outcomes can never be 100% accurately predicted. Familiarity with historical data, individual industries, and individual stocks is key to developing a robust portfolio. Note that stock prices can fluctuate rapidly during trading sessions.